Cite
Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis.
MLA
Huang, Dongmei, et al. “Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis.” Frontiers in Endocrinology, vol. 13, June 2022, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fendo.2022.920857.
APA
Huang, D., Zhang, J., Zheng, X., & Gao, M. (2022). Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis. Frontiers in Endocrinology, 13, 1–9. https://doi.org/10.3389/fendo.2022.920857
Chicago
Huang, Dongmei, Jinming Zhang, Xiangqian Zheng, and Ming Gao. 2022. “Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis.” Frontiers in Endocrinology 13 (June): 1–9. doi:10.3389/fendo.2022.920857.